Written question asked by Norman Baker (Liberal Democrat) on Tuesday, 29 February 2000, in the House of Commons. It was due for an answer on Tuesday, 7 March 2000. It was answered by Baroness Stuart of Edgbaston (Labour) on Tuesday, 7 March 2000 on behalf of the Department of Health.
Dept of Health
- Question
- To ask the Secretary of State for Health, if he will list the members of the Committee on Safety of Medicines who have, in each year from 1987 to date, declared outside interests in (a) SmithKline Beecham, (b) SmithKline and French laboratories, (c) Merck Sharpe and Dohme, (d) Pasteur Merieux and (e) the Wellcome Foundation. - Inc list and ref to Medicines Act 1968 Advisory Bodies - Annual Reports, copies in Library.
- Answer
-
Mr. Baker: To ask the Secretary of State for Health if he will list the members of the Committee on Safety of Medicines who have, in each year from 1987 to date, declared outside interests in (a) SmithKline Beecham, (b) SmithKline and French laboratories, (c) Merck Sharpe and Dohme, (d) Pasteur Merieux and (e) the Wellcome Foundation. [112835] Ms Stuart: This information is published annually in the "Medicines Act 1968 Advisory Bodies--Annual Reports" copies of which, dating back to 1987, are available in the Library, The reports include lists of interests in the pharmaceutical industry declared by each committee member. The 1999 report, which is due to be published in July this year, will include the entries in the table relating to members of the Committee on Safety of Medicines (CSM) (this information is correct as at 6 March 2000). In addition, Professor J. H. Scarffe is Head of Programmes (Career Development) at the Wellcome Trust. _________________________________________________________________________________________________. CMS member Name of company Nature of interest Professor J. Chipman SmithKline Beecham Non-personal--research grants Professor J. Darbyshire SmithKline Beecham Non-personal--support for clinical trials Professor H. Dargie SmithKline Beecham Personal--consultancy and non-personal--clinical trial Dr. M. Donaghy SmithKline Beecham Personal--shareholder Dr. B. Evans SmithKline Beecham Personal--fees and shares Professor E. Gordon-Smith Pasteur-Merieux Non-personal--research grants Professor M. Langman Merck Sharpe and Dohme Non-personal--support/research collaborations Dr. A. MacGowan SmithKline Beecham Personal--consultancy and non-personal--fellowship Professor B. Park SmithKline Beecham Non-personal--lectureship Professor J. F. Smyth SmithKline Beecham Personal--occasional meetings and non-personal--clinical trials support Professor I. Weller SmithKline Beecham Non-personal--trials and study Professor K. Woodhouse SmithKline Beecham Non-personal--clinical research trials Merck Sharpe and Dohme Non-personal--clinical research trials _________________________________________________________________________________________________.
Secondary information
- Type
- Written question
- Reference
- 112835; 345 c630W
- Session
- 1999-00
- Subjects
- Business interests Public appointments Committee on Safety of Medicines Wellcome Foundation SmithKline Beecham Merck Sharp and Dohme Pasteur Merieux
Librarians' tools
- Timestamp
- 2013-11-24 17:57:16 +0000
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_847643
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_847643
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_847643